论文部分内容阅读
比勒陀利亚大学(南非)报道了分别使用和合并使用青霉素与磺胺嘧啶(Sd)治疗肺炎的效果。他们将200个肺炎病人分为三组,分别用青霉素、磺胺嘧啶和青霉素加磺胺嘧啶进行治疗。从82例的痰中分离出来的细菌,在玻器内进行感受性试验的结果,发现有四分之一对青霉素或磺胺嘧啶有抗药性。但三组病人在治疗结果方面,却无显著差别。用青霉素加磺胺啶治疗的那组病人,平均发热期最长(5.1日);但如将病人入院前的患病期计算在内,则用青霉素治疗的一组病人,其平均发热期也与此相仿(青霉素治疗组为9.3日,青霉素磺胺治疗组为9.2日)。营
The University of Pretoria (South Africa) reported the efficacy of using and combining penicillin with sulfadiazine (Sd) in the treatment of pneumonia, respectively. They divided 200 pneumonia patients into three groups, treated with penicillin, sulfadiazine and penicillin plus sulfadiazine respectively. Bacteria isolated from sputum of 82 patients were tested for susceptibility in a glassware and found that one in four was resistant to penicillin or sulfadiazine. However, there was no significant difference between the three groups in the treatment outcome. The group of patients treated with penicillin and sulfadiazine had the longest average fever period (5.1 days); however, if the patient’s pre-admission period was taken into account, then the group of patients treated with penicillin also had an average fever period of This similar (penicillin treatment group was 9.3 days, penicillin sulfa treatment group was 9.2 days). camp